KAO JOHN E 4

What Happened

• John E. Kao, CEO of Alignment Healthcare (ALHC), sold 180,000 shares on March 10, 2026 in an open-market disposition. The weighted-average price was $18.19 per share, generating total proceeds of $3,273,552. This was a sale (not a purchase or option exercise) executed under a pre-established trading plan.

Key Details

• Transaction date: 2026-03-10; filing date: 2026-03-10 (filed same day).
• Price: weighted-average $18.19; per-share executions ranged from $17.86 to $18.57 (reporting person can provide exact breakdown on request).
• Total shares sold: 180,000; total proceeds: $3,273,552.
• 10b5-1 plan: sale executed under a Rule 10b5-1 plan adopted March 12, 2025 (footnote F1).
• Ownership note: footnote indicates the securities are held by JEK Trust (dated Feb 8, 2021), of which Mr. Kao is trustee (footnote F3).
• Timeliness: filing appears timely (transaction and report both dated 2026-03-10).

Context

• Sales under 10b5-1 plans are pre-arranged and generally routine; they do not by themselves indicate management’s current view on the company. For more granular pricing details per execution, the filer notes they will provide a breakdown of shares sold at each price within the reported range upon request.